SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-004388
Filing Date
2023-02-13
Accepted
2023-02-13 08:00:39
Documents
50
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 667999
2 ex31-1.htm EX-31.1 19536
3 ex31-2.htm EX-31.2 19495
4 ex32-1.htm EX-32.1 9673
5 ex32-2.htm EX-32.2 10699
  Complete submission text file 0001493152-23-004388.txt   3322165

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sonn-20221231.xsd EX-101.SCH 27133
7 XBRL CALCULATION FILE sonn-20221231_cal.xml EX-101.CAL 34830
8 XBRL DEFINITION FILE sonn-20221231_def.xml EX-101.DEF 131634
9 XBRL LABEL FILE sonn-20221231_lab.xml EX-101.LAB 223805
10 XBRL PRESENTATION FILE sonn-20221231_pre.xml EX-101.PRE 198412
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 376350
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 23614788
SIC: 2834 Pharmaceutical Preparations